Carbamazepine-induced Acute Interstitial Lung Disease. |
Kim, Koo , kang, Min Jung , Kim, Kyeong Tae , Lee, Joon Sang |
1Department of Rehabilitation Medicine, Dong-eui Hospital, Korea. 2Department of Internal Medicine, Dong-eui Hospital, Korea. |
Carbamazepine에 의한 급성 간질성 폐질환 증례 보고 |
김구, 강민정, 김경태, 이준상1 |
동의병원 재활의학과, 1내과 |
|
|
|
Abstract |
Seven days after starting carbamazepine therapy because of a central pain, a 67-year old man with the occlusion of left middle cerebral artery developed acute interstitial lung disease with severe dyspnea and decreased consciousness.
Initial therapy included mechanical ventilation, discontinuation of carbamazepine, and injection with epinephrine and steroid. Five days after developing the acute interstitial lung disease, his clinical status and the finding of simple chest X-ray were markedly improved.
Several days later, there was the removal of the ventilator and resolution of pulmonary symptoms. Acute interstitial lung disease is a rare fatal adverse reaction to carbamazepine therapy. However, awareness of carbamazepine-induced lung disease may reduce delays in both diagnosis and withdrawal of the drug. |
Key Words:
Carbamazepine, Acute interstitial lung disease |
|